Translate
Annovis Bio Inc
About
Annovis Bio Inc (NYSE:ANVS) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
Apr 10 2026
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
Apr 9 2026
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
Apr 2 2026
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
Mar 31 2026
Annovis Publishes Historical Review of Buntanetap in The Scientist
Recent Videos
Advancements in Precision Oncology and Healthcare Innovations
Apr 11, 2026
How to Invest in Annovis Bio (ANVS) Step by Step
Apr 09, 2026
09 April 26. Biotech Stock News. Daily Recap #English #Shorts $XBI #trading #biotechnews #dailynews
Apr 09, 2026
09 abril 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Apr 09, 2026
Financials
Revenue
$0
Market Cap
$64.65 M
EPS
-1.40